ALSO IN THIS MONTH'S ISSUE

  • Speaker Pelosi’s Unconstitutional Rx Bill
    Speaker Pelosi’s Unconstitutional Rx Bill

    Red flags have gone up regarding the vast overreach of Speaker Pelosi’s sweeping bill (H.R. 3), raising concerns that its key provisions that would enable the government to dictate prescription drug prices may be deemed unconstitutional.

  • Program Strives For More Females On Pharma Boards
    Program Strives For More Females On Pharma Boards

    In this first of a series of articles dedicated to the Women in Bio Boardroom Ready program, we discuss what the program entails and feedback from some previous participants.

  • 7 Elements Of A Successful Biotech Funding Plan
    7 Elements Of A Successful Biotech Funding Plan

    Life sciences companies seeking to raise capital or form early partnerships with strategic players often make avoidable mistakes. Here are some tips that can increase your probability of a successful transaction.

  • Crossing Over From Supplier To Sponsor
    Crossing Over From Supplier To Sponsor

    What can make a company decide to enter new therapeutic entities into clinical development after decades as a dedicated supplier to bio research labs? Here we explain the reasons and implications of ArunA Bio’s decision.

  • How Dual-Career Couples Make It Work
    How Dual-Career Couples Make It Work

    When both members of a dual-career couple are in senior leadership roles, the challenges are intense. How couples face those challenges has consequences for their teams and organizations as well as for themselves and families.

More from this month's issue

BEYOND THE PRINTED PAGE

  • What Makes A Biopharma Serial Entrepreneur Tick? Part 1

    Rob Wright explores what makes a serial entrepreneur tick (part 1) via Brad Margus, cofounder and CEO of Cerevance. Margus may have started out in the shrimping business, but he went on to found a disease specific 501c3 nonprofit, ultimately leading him to found three different biopharmaceutical companies.

  • What Makes A Biopharma Serial Entrepreneur Like Brad Margus Tick? Part 2

    In part 2 of what makes serial entrepreneur Brad Margus tick, Rob Wright explores the various lessons learned by Margus during the founding of multiple biopharmaceutical companies, along with an update on the 501c3 nonprofit organization he helped to cofound, the A-T Children’s Project.

  • The Effect Of Having A Rock Star Cofounder

    John Oyler, cofounder and CEO of BeiGene, a 9-year-old global biopharmaceutical company today valued at more than $8.5 billion, discusses the importance of having a “rock star” scientist cofounder in Xiandong Wang, Ph.D., and his impact on recruiting top talent.

More beyond the printed page articles

 EVENTS

Food Chemistry, Processed Foods & Toxicology November 29 - 30, 2019
Manila, OR
8th World Climate Change Congress December 3 - 4, 2019
london, YT
Climate- Change 2019 December 3 - 4, 2019
london, YT
Environmental Monitoring (EM) – Establishing and Improving Programs Using a Risk-based Approach December 5 - 5, 2019
1pm-2:30pm EST, Online Training
Duration:  90 Minutes
Price:  $299 - Includes Bonus Handouts!
More events....

NOVEMBER 2019 DIGITAL EDITION

2019 CMO & CRO AWARDS EDITIONS

   

@LIFESCILEADER1